Virtu KCG Holdings LLC acquired a new stake in Syneron Medical Ltd. (NASDAQ:ELOS) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 368,871 shares of the medical equipment provider’s stock, valued at approximately $4,039,000.

Several other institutional investors and hedge funds have also modified their holdings of ELOS. K2 Principal Fund L.P. acquired a new position in Syneron Medical during the 2nd quarter worth approximately $12,076,000. Vivaldi Asset Management LLC acquired a new position in Syneron Medical during the 2nd quarter worth approximately $9,644,000. SG Americas Securities LLC acquired a new position in Syneron Medical during the 2nd quarter worth approximately $5,600,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Syneron Medical by 1,259.7% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 501,440 shares of the medical equipment provider’s stock worth $5,491,000 after acquiring an additional 464,561 shares during the last quarter. Finally, Mizuho Securities USA LLC acquired a new position in Syneron Medical during the 2nd quarter worth approximately $5,037,000. Institutional investors and hedge funds own 69.17% of the company’s stock.

Separately, BidaskClub downgraded Syneron Medical from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th.

Syneron Medical Ltd. (NASDAQ:ELOS) remained flat at $11.00 during trading on Friday. The company had a trading volume of 3,905 shares. The company’s 50 day moving average is $10.90 and its 200-day moving average is $10.14. Syneron Medical Ltd. has a 52-week low of $6.18 and a 52-week high of $11.43.

TRADEMARK VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/24/virtu-kcg-holdings-llc-takes-position-in-syneron-medical-ltd-elos.html.

Syneron Medical Company Profile

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Want to see what other hedge funds are holding ELOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneron Medical Ltd. (NASDAQ:ELOS).

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Stock Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related stocks with our FREE daily email newsletter.